These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 5482502)

  • 21. Electron-microscopic localization of tritiated norepinephrine in rat brain: effect of drugs.
    Aghajanian GK; Bloom FE
    J Pharmacol Exp Ther; 1967 Jun; 156(3):407-16. PubMed ID: 6027453
    [No Abstract]   [Full Text] [Related]  

  • 22. Paradoxical amphetamine effect in hyperactive rats in relation to norepinephrine metabolism.
    Ladisich W; Volbehr H; Matussek N
    Neuropharmacology; 1970 Jul; 9(4):303-10. PubMed ID: 5466110
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence for carrier-mediated efflux of noradrenaline from the axoplasm of adrenergic nerves in rabbit atria.
    Paton DM
    J Pharm Pharmacol; 1973 Mar; 25(3):265-7. PubMed ID: 4146332
    [No Abstract]   [Full Text] [Related]  

  • 25. A metabolic basis for drug dependence.
    Doust JW
    Can Psychiatr Assoc J; 1974 Oct; 19(5):487-94. PubMed ID: 4609162
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo inhibition of 3H-noradrenaline uptake by mouse brain slices in vitro.
    Ross SB; Renyi AL
    J Pharm Pharmacol; 1966 May; 18(5):322-3. PubMed ID: 4380004
    [No Abstract]   [Full Text] [Related]  

  • 27. Serotonin and dopamine: distribution and accumulation in Aplysia nervous and non-nervous tissues.
    Carpenter D; Breese G; Schanberg S; Kopin I
    Int J Neurosci; 1971 Jul; 2(1):49-56. PubMed ID: 5161303
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents.
    Ross SB; Renyi AL
    Eur J Pharmacol; 1967 Dec; 2(3):181-6. PubMed ID: 5591516
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes in the hypertensive effects of angiotensin by adrenergic and anti-adrenergic agents].
    Schmitt H; Schmitt H
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):31-46. PubMed ID: 4296394
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of LSD on synthesis and release of 5-HT in rat brain slices.
    Hamon M; Bourgoin S; Jagger J; Glowinski J
    Brain Res; 1974 Apr; 69(2):265-80. PubMed ID: 4823095
    [No Abstract]   [Full Text] [Related]  

  • 31. The biochemical pharmacology of abused drugs. I. Amphetamines, cocaine, and LSD.
    Caldwell J; Sever PS
    Clin Pharmacol Ther; 1974 Oct; 16(4):625-38. PubMed ID: 4607666
    [No Abstract]   [Full Text] [Related]  

  • 32. EFFECT OF DRUGS ON THE UPTAKE, RELEASE, AND METABOLISM OF H3-NOREPINEPHRINE IN THE RAT BRAIN.
    GLOWINSKI J; AXELROD J
    J Pharmacol Exp Ther; 1965 Jul; 149():43-9. PubMed ID: 14334290
    [No Abstract]   [Full Text] [Related]  

  • 33. 2,5-Dimethoxy-4-methylamphetamine (DOM), a neuropharmacological examination.
    Wallach MB; Friedman E; Gershon S
    J Pharmacol Exp Ther; 1972 Jul; 182(1):145-54. PubMed ID: 4261221
    [No Abstract]   [Full Text] [Related]  

  • 34. Blockade of the nicotine-induced norepinephrine release by cocaine, phenoxybenzamine and desipramine.
    Su C; Bevan JA
    J Pharmacol Exp Ther; 1970 Nov; 175(2):533-40. PubMed ID: 5481718
    [No Abstract]   [Full Text] [Related]  

  • 35. Blockade of norepinephrine uptake by N,N'-bis-(1-naphthylmethyl)-1,4-cyclohexane bis-(methylamine) dihydrochloride in rodents.
    Lippmann W
    Biochem Pharmacol; 1969 Oct; 18(10):2495-505. PubMed ID: 5403986
    [No Abstract]   [Full Text] [Related]  

  • 36. Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines.
    Lichtensteiger W; Mutzner U; Langemann H
    J Neurochem; 1967 May; 14(5):489-97. PubMed ID: 5297947
    [No Abstract]   [Full Text] [Related]  

  • 37. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

  • 38. m-Fluorotyrosine convulsions and mortality: relationship to catecholamine and citrate metabolism.
    Weissman A; Koe BK
    J Pharmacol Exp Ther; 1967 Jan; 155(1):135-44. PubMed ID: 5297377
    [No Abstract]   [Full Text] [Related]  

  • 39. Different mechanisms of drug-induced release of noradrenaline and its congeners alpha-methylnoradrenaline and metaraminol.
    Carlsson A; Waldeck B
    Eur J Pharmacol; 1968 Sep; 4(2):165-8. PubMed ID: 5723998
    [No Abstract]   [Full Text] [Related]  

  • 40. 5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine.
    Sicuteri F; Anselmi B; Del Bianco PL
    Psychopharmacologia; 1973; 29(4):347-56. PubMed ID: 4267603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.